Literature DB >> 17519795

A new model of corneal transplantation in the miniature pig: efficacy of immunosuppressive treatment.

Urania Tavandzi1, Radek Procházka, Dusan Usvald, Jana Hlucílová, Martina Vitásková, Jan Motlík, Andrea Vítová, Martin Filipec, John V Forrester, Vladimír Holán.   

Abstract

Corneal allograft rejection is frequently studied in small rodent or rabbit models. To study mechanisms of rejection in a model that more closely mimics transplantation in humans, we performed orthotopic corneal transplantation in the miniature pig using a 7-mm diameter donor graft. Four groups of recipients were studied: 1) untreated naive, 2) untreated vascularized (high risk), 3) high-risk grafts treated by topical application of prednisolone, or 4) high-risk grafts treated with a combined systemic immunosuppression regime of oral prednisone, cyclosporine A, and mycophenolate mofetil. Both the clinical features and histological assessment of corneal graft rejection showed close similarities to graft rejection in humans. Interestingly, preliminary results indicated that topical steroid treatment was superior to systemic immunosuppression in significantly promoting graft survival. Thus, corneal transplantation in the pig represents an animal model most closely resembling corneal grafting in humans, and offers possibilities for testing various clinically applicable immunosuppressive treatments.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17519795     DOI: 10.1097/01.tp.0000261711.08833.a1

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  2 in total

1.  Anatomic Studies of the Miniature Swine Cornea.

Authors:  Sarag Abhari; Michael Eisenback; Henry J Kaplan; Eric Walters; Randall S Prather; Patrick A Scott
Journal:  Anat Rec (Hoboken)       Date:  2018-10-05       Impact factor: 2.064

2.  Adipose-derived mesenchymal stem cell administration does not improve corneal graft survival outcome.

Authors:  Sherezade Fuentes-Julián; Francisco Arnalich-Montiel; Laia Jaumandreu; Marina Leal; Alfonso Casado; Ignacio García-Tuñon; Enrique Hernández-Jiménez; Eduardo López-Collazo; Maria P De Miguel
Journal:  PLoS One       Date:  2015-03-02       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.